Bruker, Beckman Coulter, Invitrogen, PerkinElmer, Invitrogen, Luminex, ABI, NIH, Lawrence Berkeley National Laboratory, Russian Health Ministry, Thermo, Compugen, Sigma-Aldrich, Agilent | GenomeWeb

Bruker Posts 90-Percent Jump in Q1 Profit Despite Slight Revenue Slip

Bruker BioSciences this week posted a slight drop in first quarter revenues even though net income swelled by nearly 90 percent.

For the quarter ended March 31, revenues were $74.4 million, down less than 1 percent from the $74.9 million the company earned in the first quarter of 2005.

Bruker said that it spent $10.3 million on R&D in the first quarter, compared to $11 million in the comparable period last year.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.